Feto-maternal outcome of placenta previa with or without placenta accreta spectrum in tertiary hospital Dhaka
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20252313Keywords:
PAS, Hysterectomy, APGAR score, Placenta previaAbstract
Background: Placenta previa, with or without placenta accreta spectrum (PAS), is linked to significant maternal and fetal morbidity and mortality, primarily due to complications like cesarean delivery, severe antepartum/postpartum hemorrhage and preterm birth. The combined military hospital (CMH) Dhaka, with its advanced facilities and sufficient case volume, provides an ideal environment for this research. The main objective was to evaluate the feto-maternal outcomes of placenta previa with or without PAS and develop a management framework to improve these outcomes.
Methods: This retrospective study was conducted in the Department of Obstetrics and Gynecology at CMH Dhaka. The study population consisted of 99 pregnant women with placenta previa and PAS admitted between January 2023 and June 2024. Data were collected through a questionnaire, ultrasound reports, operative findings and histological reports.
Results: The mean age of participants was 29.59 years. Women with a previous cesarean section had a higher risk of placenta previa (71.71%). Planned cesarean sections were performed at 34-36 weeks of gestation in 70.7% of cases. Emergency LSCS was required in 9 cases due to antepartum hemorrhage (APH), while 88 were elective cesarean sections and 2 were incidental findings during elective LSCS. Intraoperative complications included bladder injury (47 cases) and peripartum hysterectomy (61.61%). Among the newborns, 25 (25.25%) had a birth weight of 1-2 kg and 77 (77.77%) were preterm, with 5 (5.05%) being very low birth weight. APGAR scores<6 at one minute were observed in 14 babies, while 85 babies had scores>6.
Conclusions: Placenta previa with or without PAS is strongly associated with serious maternal and fetal complications. Our study aims to formulate management guidelines to improve outcomes for both mother and baby.
Metrics
References
Jauniaux E, Chantraine F, Silver RM, Langhoff-Roos J. FIGO placenta accreta diagnosis and management expert consensus panel. FIGO consensus guidelines on placenta accreta spectrum disorders: Epidemiology. Int J Gynaecol Obstet. 2018;140:265–73. DOI: https://doi.org/10.1002/ijgo.12407
Cresswell J, Ronsmans C, Calvert C. Prevalence of placenta praevia by world region: a systematic review and meta-analysis. Trop Med Int Health. 2013;18(6):712–24. DOI: https://doi.org/10.1111/tmi.12100
Daskalakis G, Simou M, Zacharakis D, Detorakis S, Akrivos N, Papantoniou N, et al. Impact of placenta previa on obstetric outcome. Int J Gynecol Obst. 2011;114(3):238-41. DOI: https://doi.org/10.1016/j.ijgo.2011.03.012
Sarojini S, Malini KV, Radhika R. Clinical study of placenta previa and its effect on maternal health and fetal outcome. Int J Reprod, Contracep, Obst Gynecol. 2016:3496-3499. DOI: https://doi.org/10.18203/2320-1770.ijrcog20163430
Kollmann M, Gaulhofer J, Lang U, Klaritsch P. Placenta praevia: incidence,risk factors and outcome. J Maternal-Fetal amp Neon Med. 2015;29(9):1395-8. DOI: https://doi.org/10.3109/14767058.2015.1049152
Kumari S, Singh B. Maternal and perinatal outcome of placenta previa in a tertiary care centre: an observational study. Int J Reprod, Contrac, Obst Gynecol. 2018;7(11):4701. DOI: https://doi.org/10.18203/2320-1770.ijrcog20184533
Farquhar CM, Li Z, Lensen S, McLintock C, Pollock W, Peek MJ, et al. Incidence, risk factors and perinatal outcomes for placenta accreta in Australia and New Zealand:A case-control study. BMJ Open. 2017;7:10. DOI: https://doi.org/10.1136/bmjopen-2017-017713
Bowie JD, Rosenberg ER, Rosenberg ER. The fallacy of placental migration: effect of sonographic techniques. AJR Am J Roentgenol. 1985;144(1):79. DOI: https://doi.org/10.2214/ajr.144.1.79
Khan AT, Stewart KS. Ultrasound placental localisation in early pregnancy. Scott Med J. 1987;32(1):19–21. DOI: https://doi.org/10.1177/003693308703200109
Philips J, Gurganus M, DeShields S. Prevalence of sonographic markers of placenta accreta spectrum in low-risk pregnancies. Am J Perinatol. 2019;36:733–780. DOI: https://doi.org/10.1055/s-0038-1676488
Upson K, Silver RM, Greene R, Lutomski J, Holt VL. Placenta accreta and maternal morbidity in the Republic of Ireland, 2005-2010. J Matern Fetal Neonatal Med. 2014;27(1):24–9. DOI: https://doi.org/10.3109/14767058.2013.799654
Anjum F, Bashir R, Rahim A. Maternal and Foetal Outcome in Cases of Placenta Previa, Accreta and Increta. Ann King Edward Med Coll. 2016;22(4):296–300. DOI: https://doi.org/10.21649/akemu.v22i4.1469
Alchalabi H, Lataifeh I, Obeidat B, Zayed F, Khader YS, Obeidat N. Morbidly adherent placenta previa in current practice :prediction and maternal morbidity in a series of 23 women who underwent hysterectomy. J Matern Fetal Neonatal Med. 2014;7058(17):1734–7. DOI: https://doi.org/10.3109/14767058.2013.879700
Dola C, Garite T, Dowling D. Placenta previa: does its type affect pregnancy outcome. Am J Perinatol. 2003;20(7):353–60. DOI: https://doi.org/10.1055/s-2003-45282
Sekiguchi A, Nakai A, Kawabata I. Type and location of placenta previa affect preterm delivery risk related to antepartum hemorrhage. Int J Med Sci. 2013;10(12):1683–8. DOI: https://doi.org/10.7150/ijms.6416
Obstetric Care Consensus No. 7 Summary: Placenta Accreta Spectrum. Obstet Gynecol. 2018;132:1519–21. DOI: https://doi.org/10.1097/AOG.0000000000002984
Sorakayalapeta MS, Manoli N. Maternal and perinatal outcome in placenta previa: an observational study at a tertiary care hospital in Mysore, Karnataka, India. Int J Repr, Contrac, Obst Gynecol. 2019;8(4):1322. DOI: https://doi.org/10.18203/2320-1770.ijrcog20190978
Downloads
Published
How to Cite
Issue
Section
